Type 2 Diabetes Treatment Algorithm ADA Guidelines 2016 | NDEI PPT

  • This slide reviews recommendations for pharmacologic therapy for type 2 diabetes management from the 2016 ADA diabetes management guidelines.

DPP-4 inhibitor=dipeptidyl peptidase-4 inhibitor; GLP-1 RA=glucagon-like peptide-1 receptor agonist; MET=metformin; SGLT2 inhibitor=sodium glucose cotransporter 2 inhibitor; SU=sulfonylurea; TZD=thiazolidinedione

Refer to source document for full recommendations, including level of evidence rating.

American Diabetes Association. Standards of medical care in diabetes—2016. Diabetes Care. 2016;39(suppl 1):S1-S106. Inzucchi SE et al. Diabetes Care. 2015;38(1):140-149.

January 2016

This slide was created by Ashfield Healthcare Communications and was not associated with funding via an educational grant or a promotional/commercial interest.